Peter Savas, a managing partner in Tug Hill Partners LLC, is the new chairman of the board at Amphora Discovery.
Savas served formerly as president and CEO of Aderis Pharmaceuticals.
His appointment at Amphora was announced Wednesday.
Amphora has two drug compounds in preclinical development.
Amphora: www.amphoracorp.com
